Your fact-checks will appear here
Importance of transparent data sharing for independent analysis
The 2017 structured audit of 42 major pharmaceutical companies concluded that corporate were highly variable, and that “other than journal submission for all trials within 12 months, all elements of b...
A long-running debate over (individual patient) data from randomized statin trials centers on whether independent researchers can fully assess benefits and harms; campaigners and some journals demand ...
Raw patient-level data are indispensable for the fullest, independent verification of a drug or vaccine’s efficacy because they allow reanalysis, subgroup exploration, and detection of anomalies that ...